thiamine has been researched along with Diabetes Mellitus, Type 1 in 36 studies
thiamine(1+) : A primary alcohol that is 1,3-thiazol-3-ium substituted by (4-amino-2-methylpyrimidin-5-yl)methyl, methyl and 2-hydroxyethyl groups at positions 3, 4 and 5, respectively.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Excerpt | Relevance | Reference |
|---|---|---|
| "5 years, because of the presence of diabetes and sensorineural deafness, she was diagnosed with TRMA syndrome and started treatment with thiamine-HCl, followed very early by benzoyloxymethyl-thiamine (BOM-T)." | 8.80 | Long-term follow-up of diabetes in two patients with thiamine-responsive megaloblastic anemia syndrome. ( Franzese, A; Poggi, V; Tenore, A; Valerio, G, 1998) |
| "There is a lack of information regarding thiamine status in children with diabetic ketoacidosis (DKA)." | 8.31 | Thiamine status during treatment of diabetic ketoacidosis in children - tertiary care centre experience. ( Abdelaziz, TA; Atfy, M; Baz, EG; Elalawi, SM, 2023) |
| "Thiamine deficiency has been documented in adults with diabetes and in a single report of reversible encephalopathy in a child with diabetic ketoacidosis." | 7.81 | Low thiamine levels in children with type 1 diabetes and diabetic ketoacidosis: a pilot study. ( Clark, JA; Lieh-Lai, M; Rosner, EA; Strezlecki, KD, 2015) |
| "Thiamine responsive megaloblastic anemia syndrome (TRMA) is a clinical triad characterized by thiamine-responsive anemia, diabetes mellitus and sensorineural deafness." | 7.75 | Thiamine responsive megaloblastic anemia syndrome. ( Ezhilarasi, S; Ganesh, R; Gowrishankar, K; Rajajee, S; Vasanthi, T, 2009) |
| "Thiamine-responsive megaloblastic anaemia (TRMA) syndrome with diabetes and deafness was found in two patients from a Tunisian kindred." | 7.71 | A novel mutation in the SLC19A2 gene in a Tunisian family with thiamine-responsive megaloblastic anaemia, diabetes and deafness syndrome. ( Belhani, A; Berul, CI; Fleming, JC; Gritli, S; Guannouni, S; Hafsia, R; Hamdi, M; Jilani, SB; Neufeld, EJ; Omar, S; Steinkamp, MP; Tartaglini, E, 2001) |
| "Thiamine-responsive megaloblastic anemia, also known as "TRMA" or "Rogers syndrome," is an early-onset autosomal recessive disorder defined by the occurrence of megaloblastic anemia, diabetes mellitus, and sensorineural deafness, responding in varying degrees to thiamine treatment." | 7.69 | Localization of the gene for thiamine-responsive megaloblastic anemia syndrome, on the long arm of chromosome 1, by homozygosity mapping. ( Barrett, T; Buist, N; Cohen, N; Fauré, S; Mandel, H; Neufeld, EJ; Raz, T; Stagg, A; Szargel, R; Yandava, CN, 1997) |
| "Thiamine deficiency has been linked to microvascular complications in patients with diabetes mellitus (DM)." | 5.38 | Blood thiamine and its phosphate esters as measured by high-performance liquid chromatography: levels and associations in diabetes mellitus patients with varying degrees of microalbuminuria. ( Abd-Alrahman, SH; Al-Attas, OS; Al-Daghri, NM; Alfadda, AA; Sabico, S, 2012) |
| "5 years, because of the presence of diabetes and sensorineural deafness, she was diagnosed with TRMA syndrome and started treatment with thiamine-HCl, followed very early by benzoyloxymethyl-thiamine (BOM-T)." | 4.80 | Long-term follow-up of diabetes in two patients with thiamine-responsive megaloblastic anemia syndrome. ( Franzese, A; Poggi, V; Tenore, A; Valerio, G, 1998) |
| "There is a lack of information regarding thiamine status in children with diabetic ketoacidosis (DKA)." | 4.31 | Thiamine status during treatment of diabetic ketoacidosis in children - tertiary care centre experience. ( Abdelaziz, TA; Atfy, M; Baz, EG; Elalawi, SM, 2023) |
| "Thiamine-responsive megaloblastic anemia (TRMA) syndrome is a rare disease comprising a classic triad of megaloblastic anemia, diabetes mellitus, and early-onset sensorineural deafness." | 3.91 | An Adult Case of Thiamine-Sensitive Megaloblastic Anemia Syndrome Accidentally Diagnosed Myelodysplastic Syndrome. ( Kutlucan, A, 2019) |
| "Thiamine-responsive megaloblastic anemia (TRMA) is a rare autosomal recessive inherited disease characterized by the clinical triad of megaloblastic anemia, sensorineural deafness, and diabetes mellitus." | 3.91 | TRMA syndrome with a severe phenotype, cerebral infarction, and novel compound heterozygous SLC19A2 mutation: a case report. ( Cheng, Q; Ding, Y; Li, Q; Li, X; Wang, J; Wang, X; Yao, R, 2019) |
| "Thiamine deficiency has been documented in adults with diabetes and in a single report of reversible encephalopathy in a child with diabetic ketoacidosis." | 3.81 | Low thiamine levels in children with type 1 diabetes and diabetic ketoacidosis: a pilot study. ( Clark, JA; Lieh-Lai, M; Rosner, EA; Strezlecki, KD, 2015) |
| "Thiamine responsive megaloblastic anemia syndrome (TRMA) is a clinical triad characterized by thiamine-responsive anemia, diabetes mellitus and sensorineural deafness." | 3.75 | Thiamine responsive megaloblastic anemia syndrome. ( Ezhilarasi, S; Ganesh, R; Gowrishankar, K; Rajajee, S; Vasanthi, T, 2009) |
| "Thiamine-responsive megaloblastic anaemia (TRMA) syndrome with diabetes and deafness was found in two patients from a Tunisian kindred." | 3.71 | A novel mutation in the SLC19A2 gene in a Tunisian family with thiamine-responsive megaloblastic anaemia, diabetes and deafness syndrome. ( Belhani, A; Berul, CI; Fleming, JC; Gritli, S; Guannouni, S; Hafsia, R; Hamdi, M; Jilani, SB; Neufeld, EJ; Omar, S; Steinkamp, MP; Tartaglini, E, 2001) |
| "The triad of thiamine-responsive anaemia, diabetes mellitus and deafness has been reported in 15 patients with macrocytic anaemia, sometimes associated with moderate thrombocytopenia." | 3.70 | Thiamine-responsive myelodysplasia. ( Ayas, M; Bazarbachi, A; Haidar, JH; Muakkit, S; Salem, Z; Solh, H; Taher, A, 1998) |
| "Thiamine-responsive megaloblastic anemia, also known as "TRMA" or "Rogers syndrome," is an early-onset autosomal recessive disorder defined by the occurrence of megaloblastic anemia, diabetes mellitus, and sensorineural deafness, responding in varying degrees to thiamine treatment." | 3.69 | Localization of the gene for thiamine-responsive megaloblastic anemia syndrome, on the long arm of chromosome 1, by homozygosity mapping. ( Barrett, T; Buist, N; Cohen, N; Fauré, S; Mandel, H; Neufeld, EJ; Raz, T; Stagg, A; Szargel, R; Yandava, CN, 1997) |
| "We have investigated thiamine metabolism and transport in the erythrocytes of two patients from unrelated families with thiamine responsive megaloblastic anaemia associated with diabetes mellitus and sensorineural deafness." | 3.67 | Studies on thiamine metabolism in thiamine-responsive megaloblastic anaemia. ( Andria, G; De Vizia, B; Longo, G; Patrini, C; Poggi, V; Rindi, G, 1989) |
| "Erythrocyte transketolase activity (ETKA) and the effect of adding thiamine pyrophosphate have been measured in a group of 27 healthy individuals and in 37 patients diagnosed as having diabetes mellitus, anemia, polyneuritis, or malnourishment secondary to vascular disease of the brain." | 3.65 | The transketolase assay of thiamine in some diseases. ( Kjosen, B; Seim, SH, 1977) |
| "Male participants with and without type 1 diabetes were studied in the General Clinical Research Centre of the Albert Einstein College of Medicine." | 2.73 | Oral benfotiamine plus alpha-lipoic acid normalises complication-causing pathways in type 1 diabetes. ( Brownlee, M; Du, X; Edelstein, D, 2008) |
| "165 patients with symmetrical, distal diabetic polyneuropathy were randomised to one of three treatment groups entering the wash-out phase and 133/124 patients were analysed in the ITT/PP analysis: Benfotiamine 600 mg per day (n=47/43), benfotiamine 300 mg per day (n=45/42) or placebo (n=41/39)." | 2.73 | Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study. ( Achenbach, U; Bretzel, RG; Federlin, K; Gaus, W; Stracke, H, 2008) |
| "Thiamine plays an important role in the regulation of glucose metabolism and pancreatic beta-cell functioning." | 2.69 | Lipophilic thiamine treatment in long-standing insulin-dependent diabetes mellitus. ( Franzese, A; Laforenza, U; Patrini, C; Poggi, V; Tenore, A; Valerio, G, 1999) |
| "Thiamine and phosphate were thus replaced." | 1.56 | [Increasing lactate levels during treatment of diabetic ketoacidosis]. ( Feldhaus, F; Lange-Brock, N, 2020) |
| "Thiamine (vitamin B1) is an essential enzyme cofactor in most organisms required at several stages of anabolic and catabolic intermediary metabolism." | 1.42 | Biochemical changes correlated with blood thiamine and its phosphate esters levels in patients with diabetes type 1 (DMT1). ( Abd-Alrahman, SH; Al-Daghri, NM; Alharbi, M; Alokail, MS; Sheshah, E; Wani, K, 2015) |
| "Thiamine deficiency has been linked to microvascular complications in patients with diabetes mellitus (DM)." | 1.38 | Blood thiamine and its phosphate esters as measured by high-performance liquid chromatography: levels and associations in diabetes mellitus patients with varying degrees of microalbuminuria. ( Abd-Alrahman, SH; Al-Attas, OS; Al-Daghri, NM; Alfadda, AA; Sabico, S, 2012) |
| "Thiamine (75 mg/day) was commenced at a single oral dose with a rapid increase of Hb level after a few days of therapy." | 1.29 | [Wolfram syndrome. Personal experience]. ( Bizzarri, C; Conti, G; Falsini, B; Marietti, G; Perrone, F; Ricci, B; Zampino, G, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (13.89) | 18.7374 |
| 1990's | 6 (16.67) | 18.2507 |
| 2000's | 13 (36.11) | 29.6817 |
| 2010's | 9 (25.00) | 24.3611 |
| 2020's | 3 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelaziz, TA | 3 |
| Atfy, M | 3 |
| Elalawi, SM | 3 |
| Baz, EG | 3 |
| Chehayeb, RJ | 1 |
| Ilagan-Ying, YC | 1 |
| Sankey, C | 1 |
| Feldhaus, F | 1 |
| Lange-Brock, N | 1 |
| Kutlucan, A | 1 |
| Li, X | 1 |
| Cheng, Q | 1 |
| Ding, Y | 1 |
| Li, Q | 1 |
| Yao, R | 1 |
| Wang, J | 1 |
| Wang, X | 1 |
| Rosner, EA | 1 |
| Strezlecki, KD | 1 |
| Clark, JA | 1 |
| Lieh-Lai, M | 1 |
| Al-Daghri, NM | 2 |
| Alharbi, M | 1 |
| Wani, K | 1 |
| Abd-Alrahman, SH | 2 |
| Sheshah, E | 1 |
| Alokail, MS | 1 |
| Du, X | 1 |
| Edelstein, D | 1 |
| Brownlee, M | 1 |
| Vindedzis, SA | 1 |
| Stanton, KG | 1 |
| Sherriff, JL | 1 |
| Dhaliwal, SS | 1 |
| Ganesh, R | 1 |
| Ezhilarasi, S | 1 |
| Vasanthi, T | 1 |
| Gowrishankar, K | 1 |
| Rajajee, S | 1 |
| Al-Attas, OS | 1 |
| Alfadda, AA | 1 |
| Sabico, S | 1 |
| Fraser, DA | 1 |
| Diep, LM | 1 |
| Hovden, IA | 1 |
| Nilsen, KB | 1 |
| Sveen, KA | 1 |
| Seljeflot, I | 1 |
| Hanssen, KF | 1 |
| Katare, R | 1 |
| Oikawa, A | 1 |
| Cesselli, D | 1 |
| Beltrami, AP | 1 |
| Avolio, E | 1 |
| Muthukrishnan, D | 1 |
| Munasinghe, PE | 1 |
| Angelini, G | 1 |
| Emanueli, C | 1 |
| Madeddu, P | 1 |
| Ziegler, D | 1 |
| Tesfaye, S | 1 |
| Kempler, P | 1 |
| Engelen, L | 1 |
| Stehouwer, CD | 1 |
| Schalkwijk, CG | 1 |
| Lerner, EB | 1 |
| Billittier, AJ | 1 |
| Lance, DR | 1 |
| Janicke, DM | 1 |
| Teuscher, JA | 1 |
| BRODERZON, EA | 1 |
| LUKASHIK, NK | 1 |
| KOLTUNOVA, VI | 1 |
| HAUGEN, HN | 1 |
| Haupt, E | 1 |
| Ledermann, H | 1 |
| Köpcke, W | 1 |
| Davidson, A | 1 |
| Hartley, PS | 1 |
| Berman, P | 1 |
| Shuttleworth, MH | 1 |
| Jermendy, G | 1 |
| Alzahrani, AS | 1 |
| Baitei, E | 1 |
| Zou, M | 1 |
| Shi, Y | 1 |
| Thornalley, PJ | 1 |
| Babaei-Jadidi, R | 1 |
| Al Ali, H | 1 |
| Rabbani, N | 1 |
| Antonysunil, A | 1 |
| Larkin, J | 1 |
| Ahmed, A | 1 |
| Rayman, G | 1 |
| Bodmer, CW | 1 |
| Stracke, H | 1 |
| Gaus, W | 1 |
| Achenbach, U | 1 |
| Federlin, K | 1 |
| Bretzel, RG | 1 |
| Marietti, G | 1 |
| Bizzarri, C | 1 |
| Perrone, F | 1 |
| Zampino, G | 1 |
| Conti, G | 1 |
| Falsini, B | 1 |
| Ricci, B | 1 |
| Akinci, A | 1 |
| Teziç, T | 1 |
| Ertürk, G | 1 |
| Tarim, O | 1 |
| Dalva, K | 1 |
| Neufeld, EJ | 2 |
| Mandel, H | 1 |
| Raz, T | 1 |
| Szargel, R | 1 |
| Yandava, CN | 1 |
| Stagg, A | 1 |
| Fauré, S | 1 |
| Barrett, T | 1 |
| Buist, N | 1 |
| Cohen, N | 1 |
| Valerio, G | 2 |
| Franzese, A | 2 |
| Poggi, V | 4 |
| Tenore, A | 2 |
| Bazarbachi, A | 1 |
| Muakkit, S | 1 |
| Ayas, M | 1 |
| Taher, A | 1 |
| Salem, Z | 1 |
| Solh, H | 1 |
| Haidar, JH | 1 |
| Patrini, C | 2 |
| Laforenza, U | 1 |
| Villa, V | 1 |
| Rivellese, A | 1 |
| Di Salle, F | 1 |
| Iovine, C | 1 |
| Capaldo, B | 1 |
| Gritli, S | 1 |
| Omar, S | 1 |
| Tartaglini, E | 1 |
| Guannouni, S | 1 |
| Fleming, JC | 1 |
| Steinkamp, MP | 1 |
| Berul, CI | 1 |
| Hafsia, R | 1 |
| Jilani, SB | 1 |
| Belhani, A | 1 |
| Hamdi, M | 1 |
| Viana, MB | 1 |
| Carvalho, RI | 1 |
| Kjosen, B | 1 |
| Seim, SH | 1 |
| Rindi, G | 1 |
| De Vizia, B | 1 |
| Longo, G | 1 |
| Andria, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pirofosfato de Tiamina Como Coadyuvante de la Metformina en el Tratamiento de Pacientes Con Diabetes Mellitus Tipo 2[NCT04053621] | 92 participants (Anticipated) | Interventional | 2021-01-31 | Not yet recruiting | |||
| The Role of the Glucosamine Pathway and Reactive Oxygen Species in the Pathogenesis of Diabetic Complications[NCT00703989] | 21 participants (Actual) | Interventional | 2005-02-28 | Completed | |||
| Can Oral Benfotiamine Supplementation Influence Progression of Microvascular Complications in Patients With Type 1 Diabetes?[NCT00117026] | Phase 1/Phase 2 | 67 participants (Actual) | Interventional | 2005-08-31 | Completed | ||
| A Double-Blind Clinical Trial of Benfotiamine Treatment in Diabetic Nephropathy[NCT00565318] | Phase 4 | 86 participants (Anticipated) | Interventional | 2007-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for thiamine and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Current therapeutic interventions in the glycation pathway: evidence from clinical studies.
Topics: Animals; Atherosclerosis; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathie | 2013 |
Long-term follow-up of diabetes in two patients with thiamine-responsive megaloblastic anemia syndrome.
Topics: Adolescent; Anemia, Megaloblastic; Blood Glucose; Child, Preschool; Deafness; Diabetes Mellitus, Typ | 1998 |
6 trials available for thiamine and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Oral benfotiamine plus alpha-lipoic acid normalises complication-causing pathways in type 1 diabetes.
Topics: Administration, Oral; Adolescent; Adult; Analysis of Variance; Cytochrome P-450 Enzyme System; Diabe | 2008 |
The effects of long-term oral benfotiamine supplementation on peripheral nerve function and inflammatory markers in patients with type 1 diabetes: a 24-month, double-blind, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Biomarkers; Diabetes Mellitus, Type 1; Double-Blind Method; Drug Administration S | 2012 |
Can paramedics safely treat and discharge hypoglycemic patients in the field?
Topics: Brain Diseases; Consent Forms; Diabetes Mellitus, Type 1; Emergency Medical Services; Emergency Medi | 2003 |
Benfotiamine in the treatment of diabetic polyneuropathy--a three-week randomized, controlled pilot study (BEDIP study).
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type | 2005 |
Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study.
Topics: Adjuvants, Immunologic; Adult; Aged; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic | 2008 |
Lipophilic thiamine treatment in long-standing insulin-dependent diabetes mellitus.
Topics: Adolescent; Age of Onset; C-Peptide; Child; Child, Preschool; Diabetes Mellitus, Type 1; Double-Blin | 1999 |
28 other studies available for thiamine and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Thiamine status during treatment of diabetic ketoacidosis in children - tertiary care centre experience.
Topics: Child; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Female; Humans; Male; Retrospective Studies | 2023 |
Thiamine status during treatment of diabetic ketoacidosis in children - tertiary care centre experience.
Topics: Child; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Female; Humans; Male; Retrospective Studies | 2023 |
Thiamine status during treatment of diabetic ketoacidosis in children - tertiary care centre experience.
Topics: Child; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Female; Humans; Male; Retrospective Studies | 2023 |
Thiamine status during treatment of diabetic ketoacidosis in children - tertiary care centre experience.
Topics: Child; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Female; Humans; Male; Retrospective Studies | 2023 |
Addressing Cognitive Biases in Interpreting an Elevated Lactate in a Patient with Type 1 Diabetes and Thiamine Deficiency.
Topics: Beriberi; Bias; Cognition; COVID-19; Diabetes Mellitus, Type 1; Female; Humans; Lactic Acid; Pandemi | 2023 |
[Increasing lactate levels during treatment of diabetic ketoacidosis].
Topics: Blood Gas Analysis; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Female; Humans; Insulin; Thiam | 2020 |
An Adult Case of Thiamine-Sensitive Megaloblastic Anemia Syndrome Accidentally Diagnosed Myelodysplastic Syndrome.
Topics: Adult; Anemia, Megaloblastic; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diagnosis | 2019 |
TRMA syndrome with a severe phenotype, cerebral infarction, and novel compound heterozygous SLC19A2 mutation: a case report.
Topics: Adult; Anemia, Megaloblastic; Arrhythmias, Cardiac; Atrophy; Brain; Cerebral Infarction; Child; Diab | 2019 |
Low thiamine levels in children with type 1 diabetes and diabetic ketoacidosis: a pilot study.
Topics: Adolescent; Biomarkers; Child; Child, Preschool; Critical Care; Diabetes Mellitus, Type 1; Diabetic | 2015 |
Biochemical changes correlated with blood thiamine and its phosphate esters levels in patients with diabetes type 1 (DMT1).
Topics: Adult; Blood Glucose; Cholesterol; Diabetes Mellitus, Type 1; Esters; Female; Humans; Male; Metaboli | 2015 |
Thiamine deficiency in diabetes - is diet relevant?
Topics: Adult; Aged; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diet; Dietary Supplements; Female | 2008 |
Thiamine responsive megaloblastic anemia syndrome.
Topics: Anemia, Megaloblastic; Blood Glucose; Child, Preschool; Diabetes Mellitus, Type 1; Female; Follow-Up | 2009 |
Blood thiamine and its phosphate esters as measured by high-performance liquid chromatography: levels and associations in diabetes mellitus patients with varying degrees of microalbuminuria.
Topics: Adolescent; Adult; Aged; Albuminuria; Blood Glucose; Child; Child, Preschool; Cholesterol; Chromatog | 2012 |
Boosting the pentose phosphate pathway restores cardiac progenitor cell availability in diabetes.
Topics: Animals; Antigens, CD; Antigens, Ly; Apoptosis; Biomarkers; Blood Glucose; Cell Proliferation; Cell | 2013 |
Comment on: Fraser et al. The effects of long-term oral benfotiamine supplementation on peripheral nerve function and inflammatory markers in patients with type 1 diabetes: a 24-month, double-blind, randomized, placebo-controlled trial. Diabetes Care 2012
Topics: Biomarkers; Diabetes Mellitus, Type 1; Female; Humans; Male; Peripheral Nerves; Thiamine | 2012 |
[EFFECT OF THIAMINE DIPHOSPHATE ON LIPID METABOLISM IN PATIENTS WITH DIABETES MELLITUS].
Topics: Adolescent; Child; Cholesterol; Diabetes Mellitus; Diabetes Mellitus, Type 1; Humans; Insulin; Lecit | 1963 |
THE BLOOD CONCENTRATION OF THIAMINE IN DIABETES.
Topics: Blood; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Drug Therapy; Fasting; Geriatric | 1964 |
[Oral benfotiamine therapy. Thus you protect the nerves of diabetic patients].
Topics: Administration, Oral; Controlled Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetes Melli | 2004 |
Megaloblastic anaemia, diabetes and deafness in a 2-year-old child.
Topics: Anemia, Megaloblastic; Child, Preschool; Deafness; Diabetes Mellitus, Type 1; Female; Humans; Thiami | 2005 |
Evaluating thiamine deficiency in patients with diabetes.
Topics: Case-Control Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Male; Mi | 2006 |
Thiamine transporter mutation: an example of monogenic diabetes mellitus.
Topics: Adolescent; Anemia, Megaloblastic; Diabetes Mellitus, Type 1; Female; Hearing Loss, Sensorineural; H | 2006 |
High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease.
Topics: Albuminuria; Biomarkers; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies | 2007 |
[Wolfram syndrome. Personal experience].
Topics: Autoantibodies; Child, Preschool; Diabetes Mellitus, Type 1; Female; Hearing Loss, Sensorineural; Hu | 1995 |
Thiamine-responsive megaloblastic anemia with diabetes mellitus and sensorineural deafness.
Topics: Anemia, Megaloblastic; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Hearing Loss, Sensorine | 1993 |
Localization of the gene for thiamine-responsive megaloblastic anemia syndrome, on the long arm of chromosome 1, by homozygosity mapping.
Topics: Alaska; Anemia, Megaloblastic; Arabs; Chromosome Mapping; Chromosomes, Human, Pair 1; Consanguinity; | 1997 |
Thiamine-responsive myelodysplasia.
Topics: Child; Child, Preschool; Diabetes Mellitus, Type 1; Female; Hearing Loss, Sensorineural; Humans; Mal | 1998 |
Acute ischemic stroke in a young woman with the thiamine-responsive megaloblastic anemia syndrome.
Topics: Adult; Anemia, Megaloblastic; Angiography; Diabetes Mellitus, Type 1; Female; Hearing Loss, Sensorin | 2000 |
A novel mutation in the SLC19A2 gene in a Tunisian family with thiamine-responsive megaloblastic anaemia, diabetes and deafness syndrome.
Topics: Anemia, Megaloblastic; Bone Marrow Cells; Cardiomyopathy, Dilated; Carrier Proteins; Child, Preschoo | 2001 |
Thiamine-responsive megaloblastic anemia, sensorineural deafness, and diabetes mellitus: A new syndrome?
Topics: Adult; Anemia, Macrocytic; Anemia, Megaloblastic; Child; Deafness; Diabetes Mellitus; Diabetes Melli | 1978 |
The transketolase assay of thiamine in some diseases.
Topics: Anemia, Macrocytic; Anemia, Pernicious; Apoenzymes; Diabetes Mellitus; Diabetes Mellitus, Type 1; Er | 1977 |
Studies on thiamine metabolism in thiamine-responsive megaloblastic anaemia.
Topics: Anemia, Macrocytic; Anemia, Megaloblastic; Child, Preschool; Deafness; Diabetes Mellitus, Type 1; Er | 1989 |